The evolution of multimodality therapy for malignant pleural mesothelioma

Current Treatment Options in Oncology

Volumn 12, Issue 2, 2011, Pages 163-172

  Zauderer, Marjorie G ^a   Krug, Lee M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; PEMETREXED;

ARTICLE; ASBESTOSIS; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL TRIAL (TOPIC); CYTOREDUCTIVE SURGERY; DECORTICATION; EXTERNAL BEAM RADIOTHERAPY; HEMITHORACIC RADIOTHERAPY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTRACAVITARY CHEMOTHERAPY; LUNG RESECTION; MALIGNANT MESOTHELIOMA; MALIGNANT PLEURA MESOTHELIOMA; MORBIDITY; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; PARTIAL BODY RADIATION; PLEURA MESOTHELIOMA; PLEURECTOMY; PROGNOSIS; RADIATION DOSE; RECURRENT CANCER;

COMBINED MODALITY THERAPY; HUMANS; MESOTHELIOMA; PLEURAL NEOPLASMS; TREATMENT OUTCOME;

EID: 79958030031     PISSN: 15272729     EISSN: 15346277     Source Type: Journal    
DOI: 10.1007/s11864-011-0146-4     Document Type: Article

References (47)

1. L Zellos DC Christiani 2004 Epidemiology, biologic behavior, and natural history of mesothelioma Thorac Surg Clin 14 4 469 77 15559053 10.1016/j.thorsurg.2004.06.011 (Pubitemid 39314480)
2. J Peto, et al. 1999 The European mesothelioma epidemic Br J Cancer 79 3-4 666 72 10027347 10.1038/sj.bjc.6690105 1:STN:280:DyaK1M7kvFGqsQ%3D%3D (Pubitemid 29046253)
3. B Price 1997 Analysis of current trends in United States mesothelioma incidence Am J Epidemiol 145 3 211 8 9012593 1:STN:280:DyaK2s7msVygsw%3D%3D
4. B Price A Ware 2004 Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003 Am J Epidemiol 159 2 107 12 14718210 10.1093/aje/kwh025 (Pubitemid 38082517)
5. JC Wagner CA Sleggs P Marchand 1960 Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province Br J Ind Med 17 260 71 13782506 1:STN:280:DyaF3c7gt1OgsQ%3D%3D
6. SH Moolgavkar R Meza J Turim 2009 Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973-2005 Cancer Causes Control 20 6 935 44 19294523 10.1007/s10552-009-9328-9
7. EH Baldini 2004 External beam radiation therapy for the treatment of pleural mesothelioma Thorac Surg Clin 14 4 543 8 15559061 10.1016/S1547-4127(04) 00108-2 (Pubitemid 39314488)
8. S van Ruth P Baas FA Zoetmulder 2003 Surgical treatment of malignant pleural mesothelioma: a review Chest 123 2 551 61 12576380 10.1378/chest.123.2. 551 (Pubitemid 36269444)
9. MY Chang DJ Sugarbaker 2004 Extrapleural pneumonectomy for diffuse malignant pleural mesothelioma: techniques and complications Thorac Surg Clin 14 4 523 30 15559059 10.1016/j.thorsurg.2004.06.001 (Pubitemid 39314486)
10. VW Rusch S Piantadosi EC Holmes 1991 The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial J Thorac Cardiovasc Surg 102 1 1 9 2072706 1:STN:280:DyaK3MzgsVSisg%3D%3D
11. HI Pass, et al. 1997 Surgically debulked malignant pleural mesothelioma: results and prognostic factors Ann Surg Oncol 4 3 215 22 9142382 10.1007/BF02306613 1:STN:280:DyaK2s3oslaqsg%3D%3D (Pubitemid 127725247)
12. VW Rusch, et al. 2001 A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma J Thorac Cardiovasc Surg 122 4 788 95 11581615 10.1067/mtc.2001.116560 1:STN:280:DC%2BD3MrjsVektQ%3D%3D (Pubitemid 35470127)
13. HF Batirel, et al. 2008 Trimodality treatment of malignant pleural mesothelioma J Thorac Oncol 3 5 499 504 18449002 10.1097/JTO.0b013e31816fca1b (Pubitemid 351630277)
14. G Buduhan, et al. 2009 Trimodality therapy for malignant pleural mesothelioma Ann Thorac Surg 88 3 870 5 19699914 10.1016/j.athoracsur.2009.05. 036
15. M de Perrot, et al. 2009 Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma J Clin Oncol 27 9 1413 8 19224855 10.1200/JCO.2008.17.5604
16. RM Flores, et al. 2006 Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial J Thorac Oncol 1 4 289 95 17409872 10.1097/01243894-200605000-00004 (Pubitemid 47163979)
17. A Hasani, et al. 2009 Outcome for patients with malignant pleural mesothelioma referred for Trimodality therapy in Western Australia J Thorac Oncol 4 8 1010 6 19546819 10.1097/JTO.0b013e3181ae25bf
18. LM Krug, et al. 2009 Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma J Clin Oncol 27 18 3007 13 19364962 10.1200/JCO.2008.20.3943 1:CAS:528:DC%2BD1MXoslyisLo%3D This multicenter, U.S. trial is the largest prospective study of trimodality therapy. Patients received induction pemetrexed/cisplatin, followed by EPP, and then hemithoracic radiation. While the median survival was only 17 months, the 2-year survival was 37%. The best predictor of a favorable outcome was response to chemotherapy
19. K Okubo, et al. 2009 Survival and relapse pattern after trimodality therapy for malignant pleural mesothelioma Gen Thorac Cardiovasc Surg 57 11 585 90 19908112 10.1007/s11748-009-0440-2
20. V Pagan, et al. 2006 5-year prospective results of trimodality treatment for malignant pleural mesothelioma J Cardiovasc Surg (Torino) 47 5 595 601 1:STN:280:DC%2BD28ngtFegug%3D%3D (Pubitemid 44696791)
21. F Rea, et al. 2007 Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): feasibility and results Lung Cancer 57 1 89 95 17403553 10.1016/j.lungcan.2007.02.004 (Pubitemid 46843340)
22. PE Van Schil, et al. 2010 Phase II trial of trimodality therapy for malignant pleural mesothelioma (EORTC 08031) Eur Respir J 36 1362 9 20525721 10.1183/09031936.00039510
23. W Weder, et al. 2004 Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma J Clin Oncol 22 17 3451 7 15337794 10.1200/JCO.2004.10.071 1:CAS:528:DC%2BD2cXpsVWkur0%3D (Pubitemid 41103650)
24. W Weder, et al. 2007 Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma Ann Oncol 18 7 1196 202 17429100 10.1093/annonc/mdm093 1:STN:280: DC%2BD2svls1altg%3D%3D (Pubitemid 47244366)
25. RM Flores, et al. 2008 Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients J Thorac Cardiovasc Surg 135 3 620 6 18329481 10.1016/j.jtcvs.2007.10.054
26. S Bolukbas, et al. 2009 Survival after trimodality therapy for malignant pleural mesothelioma: radical pleurectomy, chemotherapy with Cisplatin/Permetrexed and radiotherapy Lung Cancer 71 75 81 19765853 10.1016/j.lungcan.2009.08.019 This is the only prospective trimodality trial using P/D reported to date. While it was a small trial with only 35 patients, the feasibility and the excellent median survival of 30 months were encouraging.
27. A Nakas, et al. 2008 The role of video assisted thoracoscopic pleurectomy/decortication in the therapeutic management of malignant pleural mesothelioma Eur J Cardiothorac Surg 33 1 83 8 18053737 10.1016/j.ejcts.2007.09. 039 (Pubitemid 350284603)
28. VW Rusch 1997 Pleurectomy/decortication in the setting of multimodality treatment for diffuse malignant pleural mesothelioma Semin Thorac Cardiovasc Surg 9 4 367 72 9352954 1:STN:280:DyaK1c%2FhtlSjsQ%3D%3D
29. G Maggi, et al. 2001 Trimodality management of malignant pleural mesothelioma Eur J Cardiothorac Surg 19 3 346 50 11251277 10.1016/S1010-7940(01) 00594-2 1:STN:280:DC%2BD3MzjvFGnsQ%3D%3D (Pubitemid 32197443)
30. NJ Vogelzang, et al. 2003 Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma J Clin Oncol 21 14 2636 44 12860938 10.1200/JCO.2003.11.136 1:CAS:528:DC%2BD2cXptlCktL4%3D (Pubitemid 46606305)
31. W Weder I Opitz R Stahel 2009 Multimodality strategies in malignant pleural mesothelioma Semin Thorac Cardiovasc Surg 21 2 172 6 19822290 10.1053/j.semtcvs.2009.07.004
32. TW Rice, et al. 1994 Aggressive multimodality therapy for malignant pleural mesothelioma Ann Thorac Surg 58 1 24 9 7518666 10.1016/0003-4975(94) 91066-9 1:STN:280:DyaK2czhtFKrug%3D%3D (Pubitemid 24243900)
33. WG Richards, et al. 2006 Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma J Clin Oncol 24 10 1561 7 16575008 10.1200/JCO.2005.04.6813 1:CAS:528:DC%2BD28XjvFykt78%3D (Pubitemid 46638779)
34. V Rusch, et al. 1994 A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma J Clin Oncol 12 6 1156 63 8201377 1:STN:280:DyaK2c3mtValsw%3D%3D (Pubitemid 24173928)
35. TR Tilleman, et al. 2009 Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study J Thorac Cardiovasc Surg 138 2 405 11 19619785 10.1016/j.jtcvs.2009.02.046
36. L Zellos, et al. 2009 A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant pleural mesothelioma J Thorac Cardiovasc Surg 137 2 453 8 19185169 10.1016/j.jtcvs.2008.07.055
37. AA Mujoomdar DJ Sugarbaker 2008 Hyperthermic chemoperfusion for the treatment of malignant pleural mesothelioma Semin Thorac Cardiovasc Surg 20 4 298 304 19251168 10.1053/j.semtcvs.2008.11.002
38. V Gupta, et al. 2005 Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma Int J Radiat Oncol Biol Phys 63 4 1045 52 16054774 10.1016/j.ijrobp.2005.03.041 (Pubitemid 41505282)
39. TD Yan, et al. 2009 Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors J Thorac Cardiovasc Surg 138 3 619 24 19698846 10.1016/j.jtcvs.2008.12.045
40. DC Rice, et al. 2007 Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma Ann Thorac Surg 84 5 1685 93 17954086 10.1016/j.athoracsur.2007.04.076 (Pubitemid 47588107)
41. AM Allen, et al. 2006 Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma Int J Radiat Oncol Biol Phys 65 3 640 5 16751058 10.1016/j.ijrobp.2006.03.012 (Pubitemid 43795851)
42. EH Baldini 2009 Radiation therapy options for malignant pleural mesothelioma Semin Thorac Cardiovasc Surg 21 2 159 63 19822288 10.1053/j.semtcvs.2009.06.009
43. EF Miles, et al. 2008 Intensity-modulated radiotherapy for resected mesothelioma: the Duke experience Int J Radiat Oncol Biol Phys 71 4 1143 50 18262369 10.1016/j.ijrobp.2007.11.011
44. Zauderer M, et al. Feasibility of pleural intensity-modulated radiation therapy (IMRT) for malignant pleural mesothelioma (MPM). IMIG. Conference, 2010
45. T Treasure, et al. 2009 The Mesothelioma and Radical surgery randomized controlled trial: the Mars feasibility study J Thorac Oncol 4 10 1254 8 19661833 10.1097/JTO.0b013e3181ae26ae
46. AS Tsao, et al. 2007 Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasion Mol Cancer Ther 6 7 1962 72 17620427 10.1158/1535-7163.MCT-07-0052 1:CAS:528:DC%2BD2sXnsV2jsrw%3D (Pubitemid 47052486)
47. LM Krug, et al. 2010 WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer Cancer Immunol Immunother 59 10 1467 79 20532500 10.1007/s00262-010-0871-8 1:CAS:528:DC%2BC3cXpt12lsLw%3D